LeMaitre Vascular Price to Free Cash Flow Ratio 2010-2025 | LMAT
Historical price to free cash flow ratio values for LeMaitre Vascular (LMAT) since 2010.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| LeMaitre Vascular Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2025-07-10 | 85.75 | 47.59 | |
| 2025-03-31 | 83.70 | $1.80 | 46.45 |
| 2024-12-31 | 91.69 | $1.63 | 56.20 |
| 2024-09-30 | 92.30 | $1.48 | 62.51 |
| 2024-06-30 | 81.59 | $1.41 | 58.00 |
| 2024-03-31 | 65.67 | $1.47 | 44.61 |
| 2023-12-31 | 56.04 | $1.32 | 42.61 |
| 2023-09-30 | 53.64 | $1.06 | 50.69 |
| 2023-06-30 | 66.08 | $0.89 | 74.49 |
| 2023-03-31 | 50.44 | $0.86 | 58.96 |
| 2022-12-31 | 44.97 | $1.04 | 43.34 |
| 2022-09-30 | 49.39 | $1.10 | 44.80 |
| 2022-06-30 | 44.28 | $1.33 | 33.41 |
| 2022-03-31 | 45.05 | $1.36 | 33.23 |
| 2021-12-31 | 48.57 | $1.41 | 34.51 |
| 2021-09-30 | 51.23 | $1.81 | 28.36 |
| 2021-06-30 | 58.76 | $2.03 | 28.89 |
| 2021-03-31 | 46.87 | $1.88 | 24.97 |
| 2020-12-31 | 38.82 | $1.65 | 23.49 |
| 2020-09-30 | 31.11 | $1.23 | 25.33 |
| 2020-06-30 | 25.17 | $0.65 | 38.50 |
| 2020-03-31 | 23.67 | $0.58 | 40.87 |
| 2019-12-31 | 34.03 | $0.51 | 66.39 |
| 2019-09-30 | 32.27 | $0.57 | 56.85 |
| 2019-06-30 | 26.35 | $0.57 | 46.27 |
| 2019-03-31 | 29.10 | $0.60 | 48.69 |
| 2018-12-31 | 22.13 | $0.81 | 27.23 |
| 2018-09-30 | 36.17 | $0.81 | 44.66 |
| 2018-06-30 | 31.20 | $0.91 | 34.17 |
| 2018-03-31 | 33.70 | $0.95 | 35.62 |
| 2017-12-31 | 29.56 | $0.82 | 35.99 |
| 2017-09-30 | 34.68 | $0.73 | 47.67 |
| 2017-06-30 | 28.89 | $0.74 | 39.28 |
| 2017-03-31 | 22.75 | $0.74 | 30.67 |
| 2016-12-31 | 23.35 | $0.73 | 31.97 |
| 2016-09-30 | 18.25 | $0.74 | 24.55 |
| 2016-06-30 | 13.09 | $0.63 | 20.79 |
| 2016-03-31 | 14.20 | $0.58 | 24.41 |
| 2015-12-31 | 15.73 | $0.50 | 31.38 |
| 2015-09-30 | 11.08 | $0.46 | 24.00 |
| 2015-06-30 | 10.93 | $0.43 | 25.31 |
| 2015-03-31 | 7.57 | $0.34 | 22.30 |
| 2014-12-31 | 6.87 | $0.26 | 26.95 |
| 2014-09-30 | 6.15 | $0.18 | 33.52 |
| 2014-06-30 | 7.36 | $0.16 | 46.64 |
| 2014-03-31 | 7.15 | $0.10 | 73.27 |
| 2013-12-31 | 7.07 | $0.17 | 41.96 |
| 2013-09-30 | 5.89 | $0.10 | 58.38 |
| 2013-06-30 | 5.73 | $0.08 | 71.65 |
| 2013-03-31 | 5.40 | $0.15 | 35.54 |
| 2012-12-31 | 4.98 | $0.22 | 22.15 |
| 2012-09-30 | 5.54 | $0.17 | 33.09 |
| 2012-06-30 | 5.16 | $0.17 | 30.60 |
| 2012-03-31 | 5.04 | $0.26 | 19.26 |
| 2011-12-31 | 5.05 | $0.07 | 70.17 |
| 2011-09-30 | 5.28 | $0.11 | 48.86 |
| 2011-06-30 | 5.99 | $0.13 | 46.73 |
| 2011-03-31 | 5.75 | $0.07 | 85.30 |
| 2010-12-31 | 5.70 | $0.28 | 20.04 |
| 2010-09-30 | 5.93 | $0.42 | 14.04 |
| 2010-06-30 | 4.71 | $0.48 | 9.90 |
| 2010-03-31 | 3.79 | $0.49 | 7.70 |
| 2009-12-31 | 4.21 | $0.31 | 13.78 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.910B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boston Scientific (BSX) | United States | $152.324B | 38.13 |
| Stryker (SYK) | United States | $149.641B | 31.29 |
| EssilorLuxottica (ESLOY) | France | $137.721B | 0.00 |
| Medtronic (MDT) | Ireland | $114.146B | 16.18 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.237B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
| ResMed (RMD) | United States | $37.534B | 28.19 |
| GE HealthCare Technologies (GEHC) | United States | $34.575B | 16.42 |
| Agilent Technologies (A) | United States | $34.457B | 22.46 |
| Terumo (TRUMY) | Japan | $25.051B | 32.54 |
| Koninklijke Philips (PHG) | Netherlands | $23.235B | 16.30 |
| Insulet (PODD) | United States | $20.934B | 82.17 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.835B | 12.10 |
| Baxter (BAX) | United States | $15.298B | 11.42 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.441B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.887B | 23.97 |
| Lantheus Holdings (LNTH) | United States | $5.776B | 14.57 |
| Prestige Consumer Healthcare (PBH) | United States | $3.897B | 17.41 |
| Perrigo (PRGO) | Ireland | $3.742B | 9.48 |
| Haemonetics (HAE) | United States | $3.724B | 16.96 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.454B | 28.70 |
| ICU Medical (ICUI) | United States | $3.341B | 24.63 |
| QuidelOrtho (QDEL) | United States | $2.135B | 14.68 |
| AtriCure (ATRC) | United States | $1.580B | 0.00 |
| Acuren (TIC) | United States | $1.397B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.272B | 16.26 |
| Green Thumb Industries (GTBIF) | United States | $1.249B | 28.09 |
| AdaptHealth (AHCO) | United States | $1.247B | 12.66 |
| Neogen (NEOG) | United States | $1.194B | 15.28 |
| BioLife Solutions (BLFS) | United States | $1.068B | 0.00 |
| InMode (INMD) | Israel | $0.963B | 9.70 |
| Kestra Medical Technologies (KMTS) | United States | $0.791B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.679B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.53 |
| Evolus (EOLS) | United States | $0.623B | 0.00 |
| CeriBell (CBLL) | United States | $0.596B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.522B | 0.00 |
| Valneva SE (VALN) | France | $0.502B | 0.00 |
| Surmodics (SRDX) | United States | $0.441B | 0.00 |
| SNDL (SNDL) | Canada | $0.373B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
| Sanuwave Health (SNWV) | United States | $0.308B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Quanterix (QTRX) | United States | $0.295B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.291B | 0.00 |
| Cerus (CERS) | United States | $0.285B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.276B | 23.27 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| ZimVie (ZIMV) | United States | $0.264B | 12.01 |
| Brainsway (BWAY) | Israel | $0.246B | 65.00 |
| Canopy Growth (CGC) | Canada | $0.232B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Biote (BTMD) | United States | $0.225B | 6.34 |
| Verano Holdings (VRNOF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.198B | 0.00 |
| Organigram Global (OGI) | Canada | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.15 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.145B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.126B | 15.53 |
| TerrAscend (TSNDF) | Canada | $0.104B | 0.00 |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.37 |
| Jin Medical (ZJYL) | China | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.086B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.081B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.071B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.070B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.040B | 53.29 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.82 |
| Safety Shot (SHOT) | United States | $0.033B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |